Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
|Study Number||Lead Group||Study Title||CIRB||Study Status|
|S1400ANCILLARY||SWOG||Ancillary Study to Evaluate Patient and Physician Attitudes; Knowledge; and Expectations Related to Return of Genomic Results in Cancer in the SWOG 1400 (S1400) Clinical Trial||Adult CIRB - Late Phase Emphasis|
|NWU2014-04-01||CLO-Northwestern University||Statin Therapy to Reduce the Risk of Recurrent Pancreatitis||Cancer Prevention and Control CIRB||Available to Open|
|9930||ETCTN||A Phase I Trial of MEDI-570 in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) Follicular Variant and Angioimmunoblastic T-Cell Lymphoma (AITL)||Adult CIRB - Early Phase Emphasis||Available to Open|
|ADVL1412||COG||A Phase 1/2 Study of Nivolumab (IND# 124729) in Children; Adolescents; and Young Adults with Recurrent or Refractory Solid Tumors as a Single Agent and in Combination with Ipilimumab||Pediatric CIRB||Available to Open|
|EAA172||ECOG-ACRIN||Phase 1/2 Study of Daratumumab, Bortezomib, Dexamethasone with or without Venetoclax in Relapsed/Refractory Multiple Myeloma with Assessment for t(11;14) Status||Adult CIRB - Late Phase Emphasis||Available to Open|
|S0931||SWOG||EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy; A Phase III Study||Adult CIRB - Late Phase Emphasis||Available to Open|
|EA3132||ECOG-ACRIN||Phase II Randomized Trial of Adjuvant Radiotherapy with or Without Cisplatin for p53 Mutated; Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)||Adult CIRB - Late Phase Emphasis||Available to Open|
|AAML1031||COG||A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC# 681239; NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD||Pediatric CIRB||Available to Open|
|10106||ETCTN||A phase I and randomized phase II study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory lymphomas||Adult CIRB - Early Phase Emphasis||Available to Open|
|RTOG-0436||RTOG||A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel; Cisplatin; and Radiation for Patients with Esophageal Cancer who are Treated without Surgery||Adult CIRB - Late Phase Emphasis||Available to Open|